I read Ash's post on the 10th as being about the overall...

I read Ash's post on the 10th as being about the overall thematic and less about JRV specifically. Anyway, it's always good to hear contrary views as it helps keep one's expectations measured.

I love reading analyst predictions with SP targets in the mid 70's, but I also take these with a pinch of salt or two whenever I read the fine print disclaimers/disclosures at the bottom. This is possibly a hangover from previously being invested in Avita ('RCEL'), where 7/7 US analysts have had the stock as 'strong buy' for 18+ months with price targets anywhere from US$30 (median) to US$60 (high), meanwhile it has traded between US$16-21 in that same period and going down a lot more than it goes up...

That said, I think the analyst calls on JRV are far more likely to come true than those on RCEL.